Flash News: OKX Lists ZeroLend's Token on its Perpetual Futures Market
NASSAU, Bahamas, May 6, 2024 /PRNewswire/ --OKX, a leading crypto exchange and Web3 technology company, has issued updates for May 6, 2024.
OKX Lists ZeroLend's Token on its Perpetual Futures Market
OKX has listed a USDT-margined ZERO perpetual futures contract today at 8:30 AM (UTC). Margin trading and Simple Earn for ZERO will also be enabled on May 7, 2024 at 4:00 AM (UTC).
ZERO/USDT perpetual futures contract specs:
Features
Details
Underlying
ZERO/USDT index
Settlement crypto
USDT
Face value
1000
Price quotation
1 ZERO value calculated in USDT equivalent
Tick size
0.0000001
Leverage
0.01-50x
Funding fee
Clamp(MA([(Best bid + Best offer) / 2 ? Spot index price] / Spot index price ? Interest), -0.75%, 0.75%), Interest = 0
Note: Funding fees are received and deducted based on the current period.
Trading hours
24/7
ZERO is the token that powersZeroLend, one of the fastest-growing multi-chain lending protocols, focusing on Liquid Restaking Tokens (LRTs), Real-World Assets (RWAs), privacy and account abstraction.
OKX is a leading global crypto exchange and innovative Web3 company. Trusted by more than 50 million global users, OKX is known for being one of the fastest and most reliable crypto apps in the world.
To learn more about OKX, download our app or visit:okx.com
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...